Literature DB >> 35262711

Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome.

Tiahna L Spencer1, Laura Watts2, Anushka Soni3, Rafael Pinedo-Villanueva3, Anne-Marie Heegaard4, Alison M Boyce5, M Kassim Javaid3.   

Abstract

CONTEXT: Pain is a major symptom in adults with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) and response to current treatments, including bisphosphonates and standard analgesics (nonsteroidal anti-inflammatory drugs and opiates) is unpredictable. No studies have explored whether the type of pain is variable in this patient group.
OBJECTIVE: To determine the frequency of neuropathic-like pain in patients with FD/MAS.
DESIGN: Retrospective, dual registry study.
SETTING: Community. PATIENTS: FD/MAS online registries: the US-based Familial Dysautonomia Foundation (FDF) and the UK-based Rare and Undiagnosed Diseases (RUDY) study. INTERVENTION: Subjects completed questionnaires to evaluate the presence of features of neuropathic-like pain (painDETECT) and the impact on sleep quality (Pittsburgh Sleep Quality Index) and mental health (Hospital Anxiety and Depression Scale). Descriptive statistics were used to characterize the prevalence and associated burden of neuropathic-like pain. MAIN OUTCOME MEASURES: Incidence of neuropathic, nociceptive, and unclear pain.
RESULTS: Of 249 participants, one third experienced neuropathic-like pain. This group had statistically significantly (P < 0.001) worse mental well-being and sleep in comparison to those with predominately nociceptive pain.
CONCLUSIONS: Neuropathic-like pain is common in patients with FD/MAS and associated with worse quality of life. Evaluation of pain in patients with FD/MAS should include assessment of neuropathic-like pain to guide personalized approaches to treatment and inform future research. Published by Oxford University Press on behalf of the Endocrine Society 2022.

Entities:  

Keywords:  McCune-Albright syndrome; fibrous dysplasia; mental health; neuropathic-like pain; nociceptive pain; quality of life

Mesh:

Year:  2022        PMID: 35262711      PMCID: PMC9113795          DOI: 10.1210/clinem/dgac120

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   6.134


  54 in total

1.  Assessment of the SF-36 version 2 in the United Kingdom.

Authors:  C Jenkinson; S Stewart-Brown; S Petersen; C Paice
Journal:  J Epidemiol Community Health       Date:  1999-01       Impact factor: 3.710

2.  Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.

Authors:  T Yamamoto; K Ozono; S Kasayama; K Yoh; K Hiroshima; M Takagi; S Matsumoto; T Michigami; K Yamaoka; T Kishimoto; S Okada
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.

Authors:  Cemre Robinson; Michael T Collins; Alison M Boyce
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

4.  Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.

Authors:  Alan J Kivitz; Joseph S Gimbel; Candace Bramson; Mary Anne Nemeth; David S Keller; Mark T Brown; Christine R West; Kenneth M Verburg
Journal:  Pain       Date:  2013-03-14       Impact factor: 6.961

5.  Validation of the Hospital Anxiety and Depression Scale for use with adolescents.

Authors:  D White; C Leach; R Sims; M Atkinson; D Cottrell
Journal:  Br J Psychiatry       Date:  1999-11       Impact factor: 9.319

6.  Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis.

Authors:  Sadaf Ashraf; Helen Wibberley; Paul Ian Mapp; Roger Hill; Deborah Wilson; David Andrew Walsh
Journal:  Ann Rheum Dis       Date:  2010-11-15       Impact factor: 19.103

Review 7.  The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis.

Authors:  Tatyana Mollayeva; Pravheen Thurairajah; Kirsteen Burton; Shirin Mollayeva; Colin M Shapiro; Angela Colantonio
Journal:  Sleep Med Rev       Date:  2015-02-17       Impact factor: 11.609

8.  Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression.

Authors:  M Riminucci; S A Kuznetsov; N Cherman; A Corsi; P Bianco; P Gehron Robey
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

9.  Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting.

Authors:  Saqa Ahmed; Tejal Magan; Mario Vargas; Abiola Harrison; Nidhi Sofat
Journal:  J Pain Res       Date:  2014-10-14       Impact factor: 3.133

Review 10.  Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic.

Authors:  Florian Bailly; Alain Cantagrel; Philippe Bertin; Serge Perrot; Thierry Thomas; Thibaud Lansaman; Laurent Grange; Daniel Wendling; Calogera Dovico; Anne-Priscille Trouvin
Journal:  RMD Open       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.